Biotech Investors & VC Firms in North America
1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.
KOMPAS VC
HørsholmPre-Seed–Series B$1.1M – $5.4M
16 people
ZEISS Ventures
OberkochenPre-Seed–Series A$550K – $5.5M
22 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
14 people
imec.xpand
LeuvenSeed–Series A$270K – $5.4M
14 people
Frontline Strategy Funds
SingaporeSeed–Growth$5M – $15M
13 people
MVM Life Science Partners
LondonSeed–Growth$20M – $100M
20 people
SucSEED Indovation
HyderabadPre-Seed–Growth
11 people
Enterprise Investors Sp. z o. o.
WarsawSeries B–Growth$21.6M – $81M
27 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage
15 people
Saltagen Ventures
Hong KongSeed–Series B
20 people
Catalys Pacific
TokyoSeed–Series A
26 people
ScaleX Ventures
AmsterdamSeed–Series A$216K – $2.2M
12 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
22 people
Systemiq Capital
LondonSeries A
16 people
Creator Fund
LondonPre-Seed–Seed$1.1M
20 people
Big Pi Ventures
AthensSeed–Growth$540K – $3.2M
16 people
Lunar Ventures
BerlinPre-Seed–Seed$500K – $2M
16 people
Debiopharm Innovation Fund
LausannePre-Seed–Series A$1M – $5M
18 people
Heal Capital
BerlinPre-Seed–Series A$1.1M – $5.4M
15 people
Exceptional Ventures
LondonPre-Seed–Seed
16 people
Hadean Ventures
OsloSeed–Growth
21 people
Monograph Capital Partners
LondonSeed–Series B
21 people
Miyako Capital
KyotoSeed–Late Stage
14 people
Related lists
Investors & VC Firms in North America (13521)Investors & VC Firms in United States (12558)Investors & VC Firms in Europe (5844)Investors & VC Firms in Global (4719)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4214)Healthtech Investors & VC Firms (4184)Enterprise Software Investors & VC Firms (4096)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.




































































































